Insulin/IGF and target of rapamycin signaling: A TOR de force in growth control

Trends in Cell Biology

Volumn 13, Issue 2, 2003, Pages 79-85

  Oldham, Sean ^a   Hafen, Ernst ^b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; RAPAMYCIN; SOMATOMEDIN;

CANCER; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; DROSOPHILA; GROWTH REGULATION; METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMAL POPULATION GROUPS; ANIMALS; BODY CONSTITUTION; DROSOPHILA PROTEINS; ENERGY METABOLISM; EUKARYOTIC CELLS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; SIGNAL TRANSDUCTION;

METAZOA;

EID: 0037306190     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(02)00042-9     Document Type: Review

References (75)

1. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 414:2001;799-806.
2. Nakae J., et al. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 22:2001;818-835.
3. Efstratiadis A. Genetics of mouse growth. Int. J. Dev. Biol. 42:1998;955-976.
4. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
5. White M.F., Yenush L. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr. Topics in Micro. and Immun. 228:1998;179-208.
6. Razzini G., et al. Different subcellular localization and phosphoinositides binding of insulin receptor substrate protein pleckstrin homology domains. Mol. Endocrinol. 14:2000;823-836.
7. Sun X.J., et al. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13:1993;7418-7428.
8. Vanhaesebroeck B., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:2001;535-602.
9. Vogt P.K. PI 3-kinase, mTOR, protein synthesis and cancer. Trends Mol. Med. 7:2001;482-484.
10. Valentinis B., Baserga R. IGF-I receptor signalling in transformation and differentiation. Mol. Pathol. 54:2001;133-137.
11. Vogelstein B., Kinzler K.W. The multistep nature of cancer. Trends Genet. 9:1993;138-141.
12. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
13. Stocker H., Hafen E. Genetic control of cell size. Curr. Opin. Genet. Dev. 10:2000;529-535.
14. Böhni R., et al. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell. 97:1999;865-875.
15. Tanaka S., et al. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules. J. Biol. Chem. 271:1996;14610-14616.
16. Skolnik E.Y., et al. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 12:1993;1929-1936.
17. Giorgetti S., et al. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Eur. J. Biochem. 223:1994;195-202.
18. Oldham S., et al. The Drosophila insulin/IGF receptor controls growth and size by modulating PtdInsP(3) levels. Development. 129:2002;4103-4109.
19. Poltilove R.M., et al. Characterization of Drosophila insulin receptor substrate. J. Biol. Chem. 275:2000;23346-23354.
20. Yenush L., et al. The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis. Mol. Cell. Biol. 16:1996;2509-2517.
21. Leevers S.J., et al. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 1:1996;6584-6594.
22. Weinkove D., et al. Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor. Curr. Biol. 9:1999;1019-1029.
23. Britton J.S., et al. Drosophila's insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional conditions. Dev. Cell. 2:2002;239-249.
24. Shioi T., et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19:2000;2537-2548.
25. Maehama T., Dixon J.E. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol. 9:1999;125-128.
26. Cantley L.C., Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4240-4245.
27. Di Cristofano A., Pandolfi P.P. The multiple roles of PTEN in tumor suppression. Cell. 100:2000;387-390.
28. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26:2001;657-664.
29. Coffer P.J., et al. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335:1998;1-13.
30. Verdu J., et al. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nat. Cell Biol. 1:1999;500-506.
31. Scanga S.E., et al. The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene. 19:2000;3971-3977.
32. Stocker H., et al. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science. 295:2002;2088-2091.
33. Stein R.C., Waterfield M.D. PI3-kinase inhibition: a target for drug development? Mol. Med. Today. 6:2000;347-357.
34. Mills G.B., et al. Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10031-10033.
35. Green D.R., Evan G.I. A matter of life and death. Cancer Cell. 1:2002;19-30.
36. Prober D.A., Edgar B.A. Growth regulation by oncogenes - new insights from model organisms. Curr. Opin. Genet. Dev. 11:2001;19-26.
37. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell. 103:2000;253-262.
38. Abraham R.T. Identification of TOR signaling complexes: More TORC for the cell growth engine. Cell. 111:2002;9-12.
39. Fafournoux P., et al. Amino acid regulation of gene expression. Biochem. J. 351:2000;1-12.
40. van Sluijters D.A., et al. Amino-acid-dependent signal transduction. Biochem. J. 351:2000;545-550.
41. Dufner A., Thomas G. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253:1999;100-109.
42. Chou M.M., Blenis J. The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr. Opin. Cell Biol. 7:1995;806-814.
43. Avruch J., et al. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26:2001;115-154.
44. Meyuhas O. Synthesis of the translational apparatus is regulated at the translational level. Eur. J. Biochem. 267:2000;6321-6330.
45. Sonenberg N., Gingras A.C. The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr. Opin. Cell Biol. 10:1998;268-275.
46. Lawrence J.C. Jr, Abraham R.T. PHAS/4E-BPs as regulators of mRNA translation and cell proliferation. Trends Biochem. Sci. 22:1997;345-349.
47. Lambertsson A. The Minute genes in Drosophila and their molecular functions. Adv. Genet. 38:1998;69-134.
48. Lachance P.E., et al. Phosphorylation of eukaryotic translation initiation factor 4E is critical for growth. Mol. Cell. Biol. 22:2002;1656-1663.
49. Montagne J., et al. Drosophila S6 kinase: a regulator of cell size. Science. 285:1999;2126-2129.
50. Miron M., et al. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nat. Cell Biol. 3:2001;596-601.
51. s6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17:1998;6649-6659.
52. Oldham S., et al. Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 14:2000;2689-2694.
53. Zhang H., et al. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14:2000;2712-2724.
54. Fingar D.C., et al. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16:2002;1472-1487.
55. Montagne J., et al. Insulin signaling: lessons from the Drosophila tuberous sclerosis complex, a tumor suppressor. Sci. STKE. 2001;E36-E39.
56. Radimerski T., et al. Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev. 16:2002;2627-2632.
57. Gao X., et al. Tsc tumour suppressor proteins antagonize amino-acid TOR signalling. Nat. Cell Biol. 4:2002;699-704.
58. Kobayashi T., et al. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8762-8767.
59. Gao X., Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15:2001;1383-1392.
60. Potter C.J., et al. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell. 105:2001;357-368.
61. Tapon N., et al. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell. 105:2001;345-355.
62. Inoki K., et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4:2002;648-657.
63. Jaeschke A., et al. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159:2002;217-224.
64. Manning B.D., et al. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell. 10:2002;151-162.
65. Potter C.J., et al. Akt regulates growth by directly phosphorylating Tsc2. Nat. Cell Biol. 4:2002;658-665.
66. Radimerski T., et al. dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1. Nat. Cell Biol. 4:2002;251-255.
67. Datta S.R., et al. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
68. Sekulic A., et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60:2000;3504-3513.
69. Britton J.S., Edgar B.A. Environmental control of the cell cycle in Drosophila: nutrition activates mitotic and endoreplicative cells by distinct mechanisms. Development. 125:1998;2149-2158.
70. Hennig K.M., Neufeld T.P. Inhibition of cellular growth and proliferation by dTOR overexpression in, Drosophila. Genesis. 34:2002;107-110.
71. Long X., et al. TOR deficiency in C. elegans causes developmental arrest and intestinal atrophy by inhibition of mRNA translation. Curr. Biol. 12:2002;1448-1461.
72. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365.
73. Hidalgo M., Rowinsky E.K. The rapamycin-sensitive signal transduction pathway as a target of cancer therapy. Oncogene. 19:2000;6680-6686.
74. Proud C.G., et al. Interplay between insulin and nutrients in the regulation of translation factors. Biochem. Soc. Trans. 29:2001;541-547.
75. Menand B., et al. Expression and disruption of the Arabidopsis TOR (target of rapamycin) gene. Proc. Natl. Acad. Sci. U. S. A. 99:2002;6422-6427.